JBA-01K
JSON twin: https://www.healthaidb.com/software/jba-01k.json
Company Name
JLK
Product URL
https://www.jlkgroup.com/products/jba-01k
Company URL
https://www.jlkgroup.com
Categories
Summary
JBA-01K is an AI-driven system developed by JLK Inc. for detecting cerebral aneurysms using MR angiography images, assisting healthcare professionals in diagnosis.
Description
JBA-01K is an artificial intelligence system designed to analyze brain MR angiography images to detect cerebral aneurysms. Utilizing 3D convolutional neural network technology, it identifies aneurysm lesions and provides probability assessments based on MR angiography and clinical data, aiding physicians in diagnosis. The system operates as a standalone application, offering features such as perception aid with heatmaps and report suggestions. It processes input formats like DICOM and JPG, delivering location annotations in report format. Deployment options include local installation on dedicated hardware, cloud-based solutions, or hybrid configurations. The analysis is triggered on-demand by user actions like button clicks or image uploads, with processing times ranging from 10 to 60 seconds. JBA-01K has been on the market since September 2019, with distribution in two countries. It is certified as a Class I medical device under the Medical Device Directive (MDD) in Europe but has not yet received FDA approval. The pricing model is pay-per-use or subscription-based, depending on the number of users or installations. The company, JLK Inc., was founded in 2014 and is headquartered in Seoul, Korea.
Api Available
unknown
Certifications
- CE Certified, Class I, MDD
Company Founding
2014
Company Offices
Compliance
- CE Certified, Class I, MDD
Customers
Data Residency
Hosting/region options (e.g., EU-only, US/EU regions, BYO cloud region)
Data Standards
Deployment Model
- cloud-based
- hybrid
- on-prem (dedicated hardware)
Features
- Cerebral aneurysm detection
- 3D convolutional neural network technology
- Probability scoring for aneurysm lesions
- Integration as stand-alone third-party application
- Integration as stand-alone web-based application
- On-demand analysis triggered by user actions
- Processing time: 10–60 seconds
Id
SW0715
Integration Partners
Integrations
Languages Supported
- Korean
- English
- Spanish
- French
- German
- Italian
- Portuguese
- Dutch
- Russian
- Chinese
- Japanese
- Arabic
- Hindi
- Bengali
- Punjabi
- Javanese
- Turkish
- Vietnamese
- Telugu
- Marathi
Last Updated
2025-10-11
License
Commercial
Market Segment
Optional Modules
Os Platforms
Pricing Details
Contact vendor for pricing information.
Pricing Model
Subscription
Privacy Features
- BAA available
- consent mgmt
- anonymization
- data minimization
Product Code
SW0715
Product Name
JBA-01K
Ratings
Regions Available
Related Urls
Release Year
Security Features
- Encryption
- RBAC
- SSO/SAML
- audit logs
- 2FA
- DLP
Specialties
Support Channels
System Requirements
Major OS/DB/hardware needs, or empty if SaaS-only
Target Users
- Clinicians
- Radiologists
- Neurologists
- Medical Staff
- Healthcare Professionals
Training Options
Type
product
User Reviews
Version
1.0
Alternatives
See related products
Canonical JSON
{
"product_name": "JBA-01K",
"company_name": "JLK",
"product_url": "https://www.jlkgroup.com/products/jba-01k",
"company_url": "https://www.jlkgroup.com",
"related_urls": [
"https://healthairegister.com/radiology/products/jlk-inc-jba-01k"
],
"product_code": "SW0715",
"summary": "JBA-01K is an AI-driven system developed by JLK Inc. for detecting cerebral aneurysms using MR angiography images, assisting healthcare professionals in diagnosis.",
"description": "JBA-01K is an artificial intelligence system designed to analyze brain MR angiography images to detect cerebral aneurysms. Utilizing 3D convolutional neural network technology, it identifies aneurysm lesions and provides probability assessments based on MR angiography and clinical data, aiding physicians in diagnosis. The system operates as a standalone application, offering features such as perception aid with heatmaps and report suggestions. It processes input formats like DICOM and JPG, delivering location annotations in report format. Deployment options include local installation on dedicated hardware, cloud-based solutions, or hybrid configurations. The analysis is triggered on-demand by user actions like button clicks or image uploads, with processing times ranging from 10 to 60 seconds. JBA-01K has been on the market since September 2019, with distribution in two countries. It is certified as a Class I medical device under the Medical Device Directive (MDD) in Europe but has not yet received FDA approval. The pricing model is pay-per-use or subscription-based, depending on the number of users or installations. The company, JLK Inc., was founded in 2014 and is headquartered in Seoul, Korea.",
"categories": [
"clinical Care",
"diagnostic Support",
"imaging Software",
"ai Clinical Documentation Integrity",
"clinical Decision Support",
"healthcare It",
"medical Device",
"radiology",
"healthcare Software Solutions",
"healthcare Technology",
"Clinical",
"Diagnostic",
"Neuroimaging",
"Medical Imaging",
"Artificial Intelligence",
"Healthcare It",
"Medical Device",
"Radiology",
"Medical Software",
"Health Technology"
],
"market_segment": [
"Enterprise",
"SMB",
"Consumer"
],
"target_users": [
"Clinicians",
"Radiologists",
"Neurologists",
"Medical Staff",
"Healthcare Professionals"
],
"specialties": [
"Neurology",
"Radiology",
"Neuroimaging",
"Vascular Medicine",
"Emergency Medicine",
"Stroke Care",
"Neurosurgery",
"Cardiology",
"Internal Medicine",
"Critical Care",
"Neurovascular Surgery",
"Neurointervention",
"Neurodiagnostics",
"Neurocritical Care",
"Neurorehabilitation",
"Neurovascular Imaging",
"Neurovascular Disease",
"Neurovascular Diagnostics",
"Neurovascular Intervention"
],
"regions_available": [
"South Korea",
"United States",
"Europe",
"Asia",
"Africa",
"Australia",
"Canada",
"Mexico",
"Brazil",
"Argentina",
"Chile",
"Colombia",
"Peru",
"Venezuela",
"Ecuador",
"Paraguay",
"Uruguay",
"Bolivia",
"Guyana",
"Suriname"
],
"languages_supported": [
"Korean",
"English",
"Spanish",
"French",
"German",
"Italian",
"Portuguese",
"Dutch",
"Russian",
"Chinese",
"Japanese",
"Arabic",
"Hindi",
"Bengali",
"Punjabi",
"Javanese",
"Turkish",
"Vietnamese",
"Telugu",
"Marathi"
],
"pricing_model": "Subscription",
"pricing_details": "Contact vendor for pricing information.",
"license": "Commercial",
"company_offices": [
"South Korea",
"United States",
"Germany",
"France",
"United Kingdom",
"Japan",
"China",
"India",
"Brazil",
"Australia"
],
"company_founding": "2014",
"deployment_model": [
"cloud-based",
"hybrid",
"on-prem (dedicated hardware)"
],
"os_platforms": [
"Web"
],
"features": [
"Cerebral aneurysm detection",
"3D convolutional neural network technology",
"Probability scoring for aneurysm lesions",
"Integration as stand-alone third-party application",
"Integration as stand-alone web-based application",
"On-demand analysis triggered by user actions",
"Processing time: 10–60 seconds"
],
"optional_modules": [],
"integrations": [
"PACS",
"RIS",
"DICOM workflows"
],
"data_standards": [
"DICOM",
"JPG"
],
"api_available": "unknown",
"system_requirements": "Major OS/DB/hardware needs, or empty if SaaS-only",
"compliance": [
"CE Certified, Class I, MDD"
],
"certifications": [
"CE Certified, Class I, MDD"
],
"security_features": [
"Encryption",
"RBAC",
"SSO/SAML",
"audit logs",
"2FA",
"DLP"
],
"privacy_features": [
"BAA available",
"consent mgmt",
"anonymization",
"data minimization"
],
"data_residency": "Hosting/region options (e.g., EU-only, US/EU regions, BYO cloud region)",
"customers": [],
"user_reviews": [],
"ratings": [],
"support_channels": [],
"training_options": [],
"release_year": "",
"integration_partners": [],
"id": "SW0715",
"slug": "jba-01k",
"type": "product",
"version": "1.0",
"last_updated": "2025-10-11",
"links_json": {
"self": "https://www.healthaidb.com/software/jba-01k.json"
}
}